Ludwig Cancer Research engages leading scientists and clinicians in an integrated effort to understand and confront the challenge of cancer. The Oxford Branch is based at the University of Oxford, UK and benefits from excellent links with the global Ludwig Cancer Research and local Oxford research communities.
Ludwig Oxford Branch researchers are investigating all stages of cancer, from the risk of disease through to new treatment opportunities. Our research groups are interested in the signalling pathways that influence cancer initiation and progression, with a focus on infection, inflammation and cancer epigenetics. We aim to advance cancer prevention, early diagnosis and effective treatment. Find out more about the Ludwig Oxford research groups.
News
Vacancies: Assistant and/or Associate Professor Level Cancer Researchers
21 September 2023
Ludwig Oxford Professor Announced
12 September 2023
Vacancy: Senior Laboratory Support Sequencing Officer
31 August 2023
Publications
-
Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia
Journal article
de Castro FA. et al, (2023), British Journal of Haematology
-
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution.
Journal article
Rodriguez-Meira A. et al, (2023), Nat Genet
-
Mapping epigenetic modifications by sequencing technologies.
Journal article
Chen X. et al, (2023), Cell death and differentiation
Seminars
